
PHVS
Pharvaris NV
Pharmaceuticals
Pharvaris NV (PHVS) Insider Trading
11 transactions reported on SEC Form 4 — executive and director buys and sells.
Buys
0
Sells
5
Net value
$-4.0M
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Modig Berndt | Chief Executive Officer | Exercise | 300,000 | $10.5M | Sep 17, 2026 |
| Bjork Elisabeth | Exercise | 35,000 | $503.6K | Sep 17, 2026 | |
| Bjork Elisabeth | Sell | 52,500 | $2.0M | Sep 17, 2026 | |
| Glassman Robert | Exercise | 14,493 | $262.9K | Sep 17, 2026 | |
| Glassman Robert | Sell | 14,493 | $558.8K | Sep 17, 2026 | |
| Lesage Anne | Chief Early Development | Sell | 20,000 | $765.5K | Sep 17, 2026 |
| Lu Peng | President | Exercise | 15,000 | $38.9K | Sep 8, 2026 |
| Lu Peng | President | Sell | 15,000 | $610.1K | Sep 8, 2026 |
| Modig Berndt | Chief Executive Officer | Sell | 2,292 | $79.7K | Aug 14, 2026 |
| Lu Peng | Chief Medical Officer | Tax | 117 | $4.1K | Jul 12, 2026 |
| Lu Peng | Chief Medical Officer | Tax | 109 | $3.8K | Jul 11, 2026 |